Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $597.94 | 36 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $118.65 | 8 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $86.65 | 5 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $65.80 | 4 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $57.54 | 3 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $56.28 | 4 | $0 (2022) |
| Grifols USA, LLC | $56.26 | 2 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $45.70 | 3 | $0 (2023) |
| Insmed, Inc. | $26.89 | 2 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.51 | 1 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $18.90 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $216.32 | 13 | AstraZeneca Pharmaceuticals LP ($45.70) |
| 2022 | $206.59 | 12 | Merck Sharp & Dohme LLC ($73.28) |
| 2021 | $175.03 | 11 | Boehringer Ingelheim Pharmaceuticals, Inc. ($41.49) |
All Payment Transactions
36 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/02/2023 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Cardiology | ||||||
| 06/01/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Respiratory | ||||||
| 04/27/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Rare Disease | ||||||
| 04/21/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/14/2023 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Cardiology | ||||||
| 04/13/2023 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Cardio-pulmonary | ||||||
| 03/30/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Respiratory | ||||||
| 03/24/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/10/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Respiratory | ||||||
| 02/22/2023 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Cardio-pulmonary | ||||||
| 02/16/2023 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Respiratory | ||||||
| 02/10/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: IMMUNOLOGY | ||||||
| 01/26/2023 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/27/2022 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/21/2022 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $40.11 | General |
| Category: Pulmonology | ||||||
| 10/07/2022 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Cardiology | ||||||
| 09/09/2022 | Bayer HealthCare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Hematology | ||||||
| 09/07/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/19/2022 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $13.64 | General |
| 08/11/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA, RECARBRIO | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/02/2022 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/20/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/22/2022 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/14/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: RESPIRATORY | ||||||
| 01/06/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA, RECARBRIO | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 49 | 52 | $31,928 | $8,475 |
| 2021 | 1 | 11 | 11 | $19,762 | $1,226 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 49 | 52 | $31,928 | $8,475 | 26.5% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 11 | 11 | $19,762 | $1,226 | 6.2% |
About Dr. Melodie Blackmon, DO
Dr. Melodie Blackmon, DO is a Critical Care Medicine healthcare provider based in Tyler, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/28/2018. The National Provider Identifier (NPI) number assigned to this provider is 1689162257.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Melodie Blackmon, DO has received a total of $597.94 in payments from pharmaceutical and medical device companies, with $216.32 received in 2023. These payments were reported across 36 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($597.94).
As a Medicare-enrolled provider, Blackmon has provided services to 60 Medicare beneficiaries, totaling 63 services with total Medicare billing of $9,700. Data is available for 2 years (2021–2023), covering 2 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Emergency Medicine
- Location Tyler, TX
- Active Since 04/28/2018
- Last Updated 07/12/2023
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1689162257
Products in Payments
- XARELTO (Drug) $86.65
- OPSUMIT (Drug) $65.80
- ZERBAXA (Drug) $60.16
- Adempas (Drug) $57.54
- Prolastin-C Liquid (Biological) $56.26
- FASENRA (Biological) $45.70
- DIFICID (Drug) $44.23
- STIOLTO RESPIMAT (Drug) $40.36
- Arikayce (Drug) $26.89
- GLASSIA (Biological) $20.51
- ULTOMIRIS (Biological) $18.90
- NUCALA (Biological) $16.26
- OFEV (Drug) $15.92
- Veklury (Drug) $14.86
- RECARBRIO (Drug) $14.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Tyler
Dr. George Gass, M.d, M.D
Critical Care Medicine — Payments: $15,168
Dr. Varalaxmi Nannaka, M.d, M.D
Critical Care Medicine — Payments: $10,883
Dr. Carla Wang-Kocik, Md, MD
Critical Care Medicine — Payments: $6,871
James Fox, Md, MD
Critical Care Medicine — Payments: $5,569
Sommer Ledkins
Critical Care Medicine — Payments: $4,773
Joseph Zasik, Do, DO
Critical Care Medicine — Payments: $3,793